Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanofi-Aventis Restructures R&D | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sanofi-Aventis Restructures R&D

Sanofi-Aventis is restructuring its R&D operation and plans to close eight of its 27 R&D sites.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi-Aventis is restructuring its R&D operation and plans to close eight of its 27 R&D sites. The new R&D model, which is expected to be in place by 2013, aims to group researchers in more productive structures, working more closely with academics and hospitals to help drive innovation. The company will focus on diabetes, cancer and age-related diseases as well as anti-inflammatory and anti-infectious diseases, according to Christian Lajoux, head of Sanofi-Aventis France.

Under the reorganization, four sites in France and sites in Britain, Japan, Spain and the U.S. will close. According to the company, there will be no layoffs at this time but a plan for voluntary departures is being considered. The company employs 13,000 people in R&D and administrative positions.

“The objective of this new R&D model is to propose innovative solutions that respond to specific, unmet needs of patients and continue our success in a very competitive international environment,” said Christopher A. Viehbacher, chief executive officer of Sanofi-Aventis. “It is centered on the real needs of patients, the development of scientific networks and openness toward outside entities to strengthen creativity, and a flexible and entrepreneurial approach to research.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics